Knight Therapeutics Inc. (FRA:04K)

Knight Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	370	360	370	404	437	446
Market Cap Growth	4.31%	-2.94%	-8.20%	-7.76%	-1.99%	-36.81%
Enterprise Value	363	280	312	322	355	216
Last Close Price	3.66	3.50	3.52	3.64	3.60	3.30
PE Ratio	-	123.63	-	-	40.16	16.54
PS Ratio	1.46	1.44	1.65	1.99	2.59	3.49
PB Ratio	0.79	0.67	0.72	0.71	0.75	0.79
P/TBV Ratio	2.04	1.26	1.43	1.44	1.51	1.07
P/FCF Ratio	18.01	15.84	15.45	13.86	15.44	-
P/OCF Ratio	17.02	14.76	15.05	12.97	14.11	-
EV/Sales Ratio	1.43	1.13	1.39	1.59	2.10	1.69
EV/EBITDA Ratio	13.71	7.46	8.55	11.38	15.73	113.34
EV/EBIT Ratio	-	56.47	71.47	-	-	-
EV/FCF Ratio	17.65	12.35	13.01	11.07	12.52	-
Debt / Equity Ratio	0.14	0.06	0.09	0.09	0.05	0.06
Debt / EBITDA Ratio	2.47	0.83	1.24	1.73	1.18	9.99
Debt / FCF Ratio	3.16	1.46	1.98	1.85	1.00	-
Asset Turnover	0.41	0.39	0.33	0.29	0.24	0.17
Inventory Turnover	1.84	2.02	1.91	1.89	1.99	1.85
Quick Ratio	1.63	2.57	2.35	2.08	2.16	4.28
Current Ratio	2.62	3.57	3.20	2.80	2.90	4.84
Return on Equity (ROE)	-0.45%	0.56%	-2.14%	-3.58%	1.81%	3.53%
Return on Assets (ROA)	-0.72%	0.48%	0.40%	-1.04%	-0.79%	-1.40%
Return on Capital (ROIC)	-0.84%	0.56%	0.46%	-1.19%	-0.88%	-1.71%
Return on Capital Employed (ROCE)	-1.30%	0.90%	0.80%	-1.90%	-1.40%	-2.80%
Earnings Yield	-0.58%	0.81%	-3.11%	-5.12%	2.49%	6.05%
FCF Yield	5.55%	6.31%	6.47%	7.22%	6.48%	-2.53%
Buyback Yield / Dilution	1.93%	5.61%	6.46%	7.74%	5.66%	5.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.